Thrombocytopathies: Not just aggregation defects—the clinical relevance of procoagulant platelets

29Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

Platelets are active key players in haemostasis. Qualitative platelet dysfunctions result in thrombocytopathies variously characterized by defects of their adhesive and procoagulant activation endpoints. In this review, we summarize the traditional platelet defects in adhesion, secretion, and aggregation. In addition, we review the current knowledge about procoagulant platelets, focus-ing on their role in bleeding or thrombotic pathologies and their pharmaceutical modulation. Pro-coagulant activity is an important feature of platelet activation, which should be specifically evaluated during the investigation of a suspected thrombocytopathy.

Cite

CITATION STYLE

APA

Aliotta, A., Calderara, D. B., Zermatten, M. G., Marchetti, M., & Alberio, L. (2021, March 1). Thrombocytopathies: Not just aggregation defects—the clinical relevance of procoagulant platelets. Journal of Clinical Medicine. MDPI. https://doi.org/10.3390/jcm10050894

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free